Legal Representation
Attorney
Edmund J. Ferdinand, III
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 10, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 10, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 4, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 8, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 8, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 8, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 8, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 8, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 7, 2025 | LOPR | P | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | Loading... |
| May 5, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 2, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 7, 2025 | LOPT | I | LETTER OF PROTEST EVIDENCE FORWARDED | Loading... |
| Nov 6, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and development
Additional Information
Design Mark
The mark consists of "TIMBERLYNE THERAPEUTICS" with the "Y" formed by the stylized molecular model of an antibody.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
TIMBERLINE THERAPEUTICS
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"